Autogenic Inhibition vs Reciprocal Inhibition for Lower Cross Syndrome
Effects of Autogenic Inhibition Versus Reciprocal Inhibition in Individuals With Lower Cross Syndrome
- Age
- 25 – 50
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 72 (estimated)
- Sponsor
- Foundation University Islamabad · Other
This trial is looking for individuals aged 25 to 50 with lower cross syndrome and chronic lower back pain. Participants will take part in comparing two different treatment techniques to see which might be more effective.
You may be able to join if
- I am between 25 and 50 years old
- I have chronic pain in my lower back that lasts more than 2 months
- I had positive results on four specific tests
You may not be able to join if
- I have osteoporosis
- I have congenital hip dysplasia
- I have a history of fractures
- I have a history of inflammatory arthritis
- I am pregnant
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThis study examines the effects of autogenic inhibition (PFS) versus reciprocal inhibition in individuals with lower cross syndrome
Loading trial locations…